Want to join the conversation?
$ABC's gross profit for 2Q16 increased by 17.9% from last year. The increases were due to the rise in gross profit of Other and of Pharmaceutical Distribution, as well as decrease in LIFO expense, which were primarily due to lower brand inflation and higher generic drug deflation.
$YHOO is reporting today after market close. Nobody cares about this stock.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.